A Miller School nephrology researcher and cell biologist has identified a cellular receptor, called fibroblast growth factor receptor 4 (FGFR4), implicated in the development of life-threatening cardiac complications in chronic kidney disease.
“Our translational study indicates that blocking FGFR4 could be a potential strategy for protecting patients with kidney disease from left ventricular hypertrophy (LVH), dangerous alterations in the structure and function of the heart muscle,” said Christian Faul, Ph.D., research associate professor in the Division of Nephrology and Hypertension and at the Katz Family Drug Discovery Center at the University of Miami Miller School of Medicine.
Allan D. Levi, M.D., Ph.D., has been named Chair of the Department of Neurological Surgery at the University of Miami Miller School of Medicine. Levi, who holds appointments in neurological surgery, orthopedics and rehabilitation medicine, joined the Miller School in 1997.
Statement from University of Miami President Julio Frenk: On behalf of the entire University of Miami community, I wish to convey our deep concern for former UM President Donna Shalala, who suffered a stroke last night. We are in continuous contact with her physicians in New York. She received the best and most advanced care, and her prognosis is now encouraging.
From lectures and mammograms, to walks, runs and a signature football game, all employees and their families are invited to take part and show their support for Sylvester patients, survivors, physicians, researchers, nurses and everyone else affected by breast cancer.
The findings of a major commission on women and health will take center stage at the Miller School of Medicine on Thursday, October 1, as Felicia Knaul, Ph.D., leads a panel discussion of a Lancet study that found women are contributing around $3 trillion to global health care, but nearly half of this is unpaid and unrecognized.
A collaborative Bascom Palmer Eye Institute and Florida International University (FIU) biomedical engineering team has developed a breakthrough retinal imaging technology that could help clinicians diagnose and assess the extent of vision loss in patients with a wide range of conditions.